MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-12-2024
Natera ROA Ratio 2011-2026 | NTRA
Annual ROA Ratio Natera
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -39.28 | -38.15 | -24.65 | -21.42 | -47.79 | -76.25 | -45.46 | -26.49 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -21.42 | -76.25 | -39.94 |
Quarterly ROA Ratio Natera
| 2024-Q3 | 2023-Q4 | 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.99 | - | -12.11 | -24.22 | -35.75 | -35.18 | -48.83 | -32.33 | -38.59 | -33.31 | -26.06 | -16.45 | -22.49 | -20.2 | -19.37 | -21.42 | -27.26 | -34.33 | -41.38 | -47.79 | -57.92 | -59.86 | -60.79 | -64.13 | -60.12 | -59.49 | -56.93 | -45.46 | -36.12 | -30.42 | -26.85 | -26.49 | -16.82 | -7.16 | -0.16 | 3.61 | 2.6 | -0.42 | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.61 | -64.13 | -30.86 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Trinity Biotech plc
TRIB
|
0.78 | $ 0.65 | -1.84 % | $ 61.9 M |  Irlanda |
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Agilent Technologies
A
|
11.3 | $ 115.55 | 1.0 % | $ 35.1 B |  USA |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | USA |
 |
Aspira Women's Health
AWH
|
-234.24 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M |  Israel |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
-189.54 | $ 1.67 | -2.34 % | $ 2.22 M | USA |
 |
Castle Biosciences
CSTL
|
3.43 | $ 24.46 | 3.25 % | $ 679 M | USA |
 |
CareDx, Inc
CDNA
|
-5.17 | $ 21.23 | 5.83 % | $ 1.13 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
10.49 | $ 84.33 | 1.82 % | $ 5.69 B | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 16.31 | 1.75 % | $ 493 M | USA |
 |
Medpace Holdings
MEDP
|
22.84 | $ 410.54 | 4.35 % | $ 11.8 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 169.8 | 1.23 % | $ 8.42 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
Guardant Health
GH
|
-20.67 | $ 88.91 | 1.18 % | $ 11.1 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
72.63 | $ 1.98 | -2.37 % | $ 8.76 M | USA |
 |
Illumina
ILMN
|
-19.4 | $ 127.88 | 1.95 % | $ 20.3 B | USA |
 |
National Research Corporation
NRC
|
8.6 | $ 17.23 | -0.12 % | $ 386 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
10.73 | $ 27.47 | -0.58 % | $ 20 B |  Niderland |
 |
Personalis
PSNL
|
-30.08 | $ 6.1 | 3.39 % | $ 361 M | USA |
 |
QIAGEN N.V.
QGEN
|
6.76 | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
-83.65 | $ 2.14 | -0.47 % | $ 4.92 M | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 102.17 | -3.92 % | $ 8.43 B | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 263.8 | -0.43 % | $ 21.9 B | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
Celcuity
CELC
|
-37.95 | $ 121.03 | 6.58 % | $ 5.66 B | USA |
 |
Thermo Fisher Scientific
TMO
|
6.08 | $ 469.71 | 0.64 % | $ 177 B | USA |
 |
NeoGenomics
NEO
|
-7.94 | $ 8.29 | 4.8 % | $ 1.06 B | USA |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 9.54 | 2.03 % | $ 2.07 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-12.1 | $ 60.94 | 3.55 % | $ 3.64 B | USA |
 |
Myriad Genetics
MYGN
|
-51.78 | $ 4.78 | -0.21 % | $ 443 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
6.11 | $ 196.27 | -1.66 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
-5.11 | - | - | $ 21.2 M | USA |
 |
Organovo Holdings
ONVO
|
-16.98 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
121.6 | - | -16.95 % | $ 1.54 M | USA |
 |
Waters Corporation
WAT
|
12.66 | $ 309.87 | -0.43 % | $ 18.5 B | USA |